Adult stem cells are multipotent and persist in small numbers in adult tissues throughout the lifespan of an organism. Unlike differentiated cells, adult stem cells are intrinsically resistant to senescence. It is unclear how adult stem cells in solid organs respond to oncogenic stimulation and whether these cells have a role in tumor initiation. We report here that expression of BRAF V600E in human neural crest progenitor cells (hNCPCs) did not induce growth arrest as seen in human melanocytes, but instead, increased their cell proliferation capacity. These cells (hNCPCs V600E ) acquired anchorage-independent growth ability and were weakly tumorigenic in vivo. Unlike in human melanocytes, BRAF V600E expression in hNCPCs did not induce p16 INK4a expression. BRAF V600E induced elevated expression of CDK2, CDK4, MITF and EST1/2 protein in hNCPCs, and also induced melanocytic differentiation of these cells. Furthermore, overexpression of MITF in hNCPCs V600E dramatically increased their tumorigenicity and resulted in fully transformed tumor cells. These findings indicate that hNCPCs are susceptible to BRAF V600E -induced transformation, and MITF potentiates the oncogenic effect of BRAF V600E in these progenitor cells. These results suggest that the hNCPCs are potential targets for BRAF V600E -induced melanocytic tumor formation.
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INTRODUCTION
Neural crest progenitor cells (NCPCs) persist in the adult in a number of differentiated tissues, such as dermis, hair follicles, peripheral nerve, gut and the heart. [1] [2] [3] [4] [5] Cell fate mapping studies using transgenic mice confirm that neural crest cells are present in the bulge and dermal papilla of hair follicles. 6 Hair follicles are a niche for NCPCs in the skin. 1, 5, 7, 8 We and others have shown that adult NCPCs can be isolated from rodent and human hair follicles 5, [7] [8] [9] [10] and they can give rise to multiple cell types, including melanocytes, Schwann cells and smooth muscle cells. 5, 8, 10 Hair follicle-derived mouse neural crest stem cells have similar gene expression profiles as embryonic neural crest stem cells. 11 A number of cancers, such as neuroblastoma, medullary thyroid cancer, Ewing sarcoma and melanoma, are known to be of neural crest origin. Adult stem cells including NCPCs have characteristics that are similar to malignant cells. 12, 13 For example, adult stem cells have remarkable longevity and self-renewal capacities and NCPCs in particular can migrate to distant body parts where they frequently form new tissues and biological structures.
14 Long-lived stem cells have inherent characteristics that inhibit their own senescence and allow these cells to survive under stress. 15, 16 It is possible that these changes in adult stem cells circumvent protective mechanisms (such as oncogene-induced senescence) that would normally prevent cancer development. Perhaps these properties of adult stem cells mean that fewer steps are required to transform these cells into cancer cells, compared with more differentiated cells. Indeed, it has been reported that the mutation of a single gene in hematopoietic stem cells can lead to increased stem cell self-renewal and transformation in vivo. 17 Compared with hematopoietic stem cells, adult stem cells from solid organs are technically more difficult to isolate, and it is not clear how these cells respond to oncogene-induced transformation.
Melanocytic nevi often grow for a period of time, then stop growth and persist locally. 18 A majority of nevi harbor BRAF mutation. The most common BRAF mutation (90%) results in a valine-to-glutamic acid change at amino acid 600 (V600E). 19 It is well documented that expression of BRAF V600E in foreskin primary human melanocytes induced cell cycle arrest and senescence; 20 and it is unknown that how BRAF V600E induces initial growth of human nevi. On the other hand, expression of BRAF V600E under MITF or tyrosinase promoter induces nevus-like growth of melanocytes in transgenic zebrafish or mouse. 21, 22 We hypothesize that the timing of mutant BRAF acquisition during neural crest lineage development determines its function in melanocytic lesion formation. In this work, we test this hypothesis by investigating the role of BRAF V600E in the transformation of human skin NCPCs.
RESULTS

BRAF
V600E increases cell proliferation capacity of hNCPCs
We previously showed that human NCPCs (hNCPCs) can be isolated from hair follicles by culturing disassociated follicular epithelium in human embryonic stem cell (hESC) culture conditions. 8, 23 Human NCPCs were infected with BRAF V600E /p Babe viral vectors and expanded in blasticidin containing Tu 2% medium (2% serum without other growth factors). We performed RT-PCR analysis using primers specific for BRAF V600E , 20 and confirmed the expression of BRAF V600E in hNCPCs (hNCPCs V600E , data not shown). To assay mitogen-activated protein kinase (MAPK) pathway activation, we performed western blotting analysis and the results showed that phosphorylated MEK and ERK levels were increased in hNCPCs V600E , compared with controls ( Figure 1a) .
As sustained expression of BRAF V600E -induced senescence in primary human melanocytes and fibroblasts, 20 we analyzed senescent responses to BRAF V600E in hNCPCs. Less than 1% of the cells were positive for senescence-associated acidic b-galactosidase activity (SA-b-Gal) in passage-8 control hNCPCs or hNCPCs V600E , indicating that BRAF V600E does not induce senescence in hNCPCs. At passage-16, 32% of control hNCPCs showed SA-b-Gal activity in Tu 2% medium. In contrast, o5% of hNCPCs V600E at passage-31 were positive for SA-b-Gal activity (Figure 1b) . These results support that BRAF V600E does not induce senescence in hNCPCs. We then compared the proliferation rate of hNCPCs V600E with control hNCPCs. There was no significant difference in early passage cells (Figure 1c ). However, hNCPCs at passage-16 grew significantly slower than hNCPCs at passage-8 in the Tu 2% medium, while hNCPCs V600E at passage-31 still grew at a similar rate as hNCPCs V600E at passage-8 ( Figure 1c ). This result was further supported by cell cycle analysis of passage-31 hNCPCs V600E and passage-16 control hNCPCs: 23.77% of hNCPCs V600E were in S phase and 12.23% were in G2-M. In contrast, 11.38% of hNCPCs were in S1 phase and 4.98% were in G2-M phase (Figure 1d ). Although hNCPCs grew in the hESC medium for over 8 months and survived 70 passages (data not shown), the hNCPCs stopped proliferating in the Tu 2% medium after just 20 passages, in contrast hNCPCs V600E continued to grow after 50 passages in the Tu 2% medium (data not shown).
To demonstrate that the effect of BRAF V600E on hNCPCs depends on functional BRAF V600E , we inhibited the function of BRAF V600E in hNCPCs V600E using either a BRAF V600E -specific inhibitor (PLX-4720) or a small interfering RNA to BRAF V600E as previously described. 24 Western blotting analysis showed that PLX-4720 inhibited ERK phosphorylation ( Figure 2a Anchorage-independent growth is an important feature for cell transformation in vitro. We found that hNCPCs V600E formed colonies in soft agar, although the number of colonies was significantly less than colonies formed by WM793 human melanoma cells (Figures 3a and c) . In contrast, control hNCPCs did not form any colonies in the soft agar (Figure 3a) . In soft agar, the hNCPCs V600E exhibited enlarged nuclei with increased nucleus/cytoplasm ratios ( Figure 3b , H&E stain). In addition, many cells in these colonies were positive for Ki67, indicating that they are proliferating (Figure 3b , Ki67 stain). These cells expressed MITF and tyrosinase but not cytokeratins (Figure 3b Figure 1) . There was no evidence of metastatic tumors in any of these mice.
Copy number aberrations in hNCPCs V600E
To rule out genetic alterations in the donor tissues and study whether BRAF V600E induces additional genetic alterations in hNCPCs, we performed array comparative genomic hybridization (CGH) on hNCPCs. This analysis was performed on two hNCPC samples from different donors before and after BRAF V600E viral infection. The two pairs of hNCPC samples showed few DNA copy number changes; the changes detected were concentrated within telomere regions (Figure 4f ). Despite these sporadic telomeric changes, there were no consistent gene copy number changes within these samples, suggesting that the few genetic alterations observed in these cells are likely the result of cell culture-induced alterations and not BRAF V600E expression. 25 Mechanisms underlying BRAF V600E -induced transformation and differentiation of hNCPCs We performed western blotting analysis to measure the expression of Cyclin-dependent kinases 2 and 4 (CDK2 and CDK4) in hNCPCs V600E . The expression of both CDK2 and CDK4 proteins was elevated compared with the expression in control cells (Figure 5a ). BRAF V600E expression in human melanocytes has been shown to induce cell cycle arrest, which is accompanied by the induction of p16 INK4a . 20 Figure 2) . The expression of phosphorylated RB protein increased in hNCPCs after BRAF V600E expression (Figure 5c ), whereas no significant changes were detected in the expression levels of p21 and p27 (data not shown). Pten expression level did not change in hNCPCs V600E (Figure 5c ). Moreover, no change was observed in telomerase activity in these cells (data not shown).
Ets1/2 is a transcription factor involved in pigmented cell differentiation and is a downstream target of MAPK/ERK activation. 26 We found that Ets1/2 expression level increased in hNCPCs V600E . Our western blotting and RT-PCR analysis showed that MITF protein and mRNA levels were elevated in hNCPCs V600E cells (Figures 5c and d) . Meanwhile, luciferase assays revealed that BRAF V600E increased MITF promoter-luciferase activity (Figure 5e ). hNCPCs V600E expressed higher level of tyrosinase mRNA compared with the control cells (Figure 5f ), supporting that BRAF V600E induces melanocytic differentiation of hNCPCs.
MITF cooperates with BRAF V600E to increase proliferative capacity of hNCPCs in vitro It has been shown that oncogenic BRAF V600E upregulates MITF transcription through transcription factor BRN2 (N-Oct3). 27 We found that BRN2 was expressed in hNCPCs and its expression level was significantly increased after BRAF V600E lentivirus infection ( Figure 6a ). As MITF is a known oncogene in melanoma and regulates the expression of key cell cycle regulatory proteins such as CDK2 and CDK4, we studied whether MITF cooperates with BRAF V600E in hNCPC transformation. To this end, we infected hNCPCs and hNCPCs V600E with viruses carrying control or MITF vectors (these cells were designated as hNCPCs MITF and hNCPCs V600E þ MITF ). MITF overexpression was confirmed by quantitative RT-PCR (data not shown) and western blotting analysis (Figure 6b ). Cell proliferation assays showed that MITF alone had little effect on hNCPC proliferation (data not shown). When we performed soft agar assays, we found that hNCPCs V600E þ MITF were (Figure 7a) . Because of the rapid growth of the hNCPCs V600E þ MITF xenografts, these mice had to be killed 5 weeks post-injection (Figure 7b ). Upon euthanasia, necropsy was performed and all the major organs were collected for histology. Histologically, hNCPCs V600E were confined to areas containing Matrigel, whereas hNCPCs V600E þ MITF formed expansile dermal tumors with focal tumor necrosis, had high grade atypical cytological features similar to human malignant melanoma cells and invaded into surrounding skeletal muscle (Figure 7c) . Most of the hNCPCs V600E þ MITF in the xenografts were positive for Ki67 staining. Nevertheless, none of these mice developed metastasis, suggesting that these cells do not possess metastatic capacity.
DISCUSSION
In this study, our findings support that skin NCPCs are susceptible to BRAF V600E -induced transformation. Specifically, we found that BRAF V600E expression did not induce growth arrest in skin hNCPCs, in contrast to what occurs in either melanocytes or fibroblasts. 20 Rather, BRAF V600E expression in hNCPCs induced anchorageindependent growth and weak tumorigenecity in vivo. Our studies suggest that lack of p16
INK4a induction and inactivation of RB in hNCPCs have a key role in bypassing BRAF V600E -induced senescence. BRAF V600E also induces the expression of MITF, which contributes to melanocytic differentiation of hNCPCs. MITF potentiates the transforming effect of BRAF V600E in hNCPCs. These results suggest that BRAF V600E mutation occurring in NCPCs results in early transformation, whereas occurring in mature melanocytes results in cellular senescence.
Adult stem cells are normally located in a niche microenvironment that usually protects them from oncogenic insults. 28 NCPCs in the skin are concentrated in the hair bulge 5, 6, 10 or dermal papilla, 1 well-defined stem cell niches. 29 It has been shown that hematopoietic stem cells can be transformed by inactivation of a single gene, such as Fbxw7. 30 Genetic mutations in normal hematopoietic stem cells may give rise to tumor stem cells and lead to leukemia. 31, 32 It is controversial whether adult stem cells in solid organs are susceptible to transformation. It has been shown that human adult stem cells can spontaneously transform after long-term culture in vitro. 33, 34 Other studies have revealed that bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term culture 35 and neural stem cells are resistant to Myc and Ras oncogene-induced transformation. 36 Our results indicate that skin NCPCs are susceptible to BRAF V600E -induced transformation, however, additional genetic alteration, such as MITF overexpression, are necessary to induce fully malignant phenotypes.
Oncogene-induced senescence, a paradoxical growth arrest that occurs after aberrant activation of oncogenes, is recognized as a major barrier to tumor development. [37] [38] [39] [40] [41] Melanocytic nevi (moles), frequently harbor BRAF V600E , yet only a minority progress to malignant melanomas. 19 Overexpression of BRAF V600E in cultured human melanocytes induces oncogene-induced senescence, and senescence is a common feature seen in nevi. 20 We and others have previously shown that a minor population of human melanocytes with elevated levels of nestin or BrdU-retaining capacity survives and proliferates for months in vitro after BRAF V600E lentivirus infection, 42, 43 suggesting that melanocytes with features of progenitor cells are less susceptible to BRAF V600E -induced senescence. Our current study further demonstrates that BRAF V600E expression in hNCPCs does not induce senescence and but results in early transformation of these cells. Nevertheless, the tumorigenecity is rather weak in vivo. These data demonstrate that activation of BRAF V600E in hNCSCs results in different outcome as that in human melanocytes. p16 INK4a is a critical cell cycle regulator and its expression is elevated in replicative senescence. p16
INK4a induction is a critical component of BRAF V600E -induced senescence in human melanocytes. 20 p16 INK4a is known to inhibits CDK4-and CDK6-mediated phosphorylation of pRB, resulting in cell growth arrest. 44 Our results confirmed that expression of p16
INK4a increases with passages in cultured human FOM and BRAF V600E also induces expression of p16
INK4a in these cells. However, we found that hNCPCs express little p16
INK4a and p16 INK4a expression is not significantly increased after BRAF V600E expression in vitro or in vivo.
The lack of p16
INK4a induction in hNCPCs after BRAF V600E expression is associated with increased CDK2 and CDK4 expression, as well as inactivation of RB. These data support that intrinsic stem cell characters of hNCPCs have a critical role in bypassing BRAF V600E -induced senescence. MITF is a transcription factor that has a pivotal role in the melanocyte differentiation, proliferation and transformation; and it is a lineage survival oncogene that is often amplified in malignant melanoma. 45 MITF is known to upregulate CDK2 and CDK4, as well as other survival factors, such as BCL2. 45, 46 It has been shown that nevi with BRAF mutations have elevated MITF expression. 47 Wellbrock et al. 27 also reported that BRAF V600E , but not wild-type BRAF, upregulate MITF transcription in the presence of BRN2. In this study, we found that hNCPCs express BRN2 and BRAF V600E increases MITF expression in hNCPCs. To study the interaction between MITF and mutant BRAF, we overexpressed MITF in hNCPCs V600E . hNCPCs V600E þ MITF displayed features of fully transformed tumor cells, such as severe cytological atypia, tumorigenicity and capacity of invading surrounding tissues. MITF has been shown to be an anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on Mitf-mediated activation of the p21 Cip1 in melanocytes 48 and BRAF V600E is a senescence inducer in adult melanocytes. 20 However, MITF and BRAF V600E co-expression confers factor-independent growth in hTERT/CDK4(R24C)/p53DD melanocytes. 45 Our data demonstrated that MITF and BRAF V600E co-expression fully transforms hNCPCs. These data suggest that function of MITF and BRAF V600E depends on the recipient cell proliferation or differentiation state. Despite the dramatic increase of tumorigenicity, hNCPCs V600E þ MITF were not capable of metastasis, indicating additional genetic or epigenetic alterations are required for tumor metastasis. Although the role of adult stem cells in solid cancer initiation is yet to be fully defined, our findings underscore crucial difference between adult stem cells and differentiated cells in response to oncogenic stimulus. Our results indicate that hNCPCs are susceptible to the transforming effects of BRAF V600E , and suggest that skin NCPCs are a potent target of mutant BRAF-induced melanocytic tumor formation.
MATERIALS AND METHODS
Plasmids and reagents
We used the pBABE-puro retroviral backbone (courtesy of M Herlyn; The Wistar Institute, Philadelphia, PA, USA) to express human BRAF V600E as previously described. 43 Production of retrovirus was achieved as previously described. 43 The myc-tagged BRAF V600E cDNA in the pEFP expression vector was kindly provided by Richard Marais from the Institute of Cancer Research, London, UK; and the MITF promoter-luciferase vector was kindly 
Human NCSC isolation and viral infection
Hair follicles were plucked from dispase-treated fetal (Advanced Bioscience Resources, Alameda, CA, USA) or adult scalp tissue (Cooperative Human Tissue Network). The protocol was approved by the University of Pennsylvania Institutional Review Board. The hair follicle epithelium was disassociated into single-cell suspensions using trypsin as previously described. 8 Disassociated follicular epithelium was cultured in conditioned hESC medium, 49 and hNCPCs grew in this medium as both spheroid aggregates and attached cells and reached confluence after 3-4 weeks.
The spheroids were enzymatically-dissociated into single cells before plating onto tissue culture-grade plastics, coated with 10 ng/ml fibronectin for transfection. BRAF V600E /pBabe, empty pBabe, GFP control, QCXIP-MITF or QCXIP control vectors were used to infect hNCPCs. After infection, BRAF V600E /pBabe infected hNCPCs (hNCPCs V600E ) were selected in Tu 2% medium (MCDB153/L15 medium (v/v: 4/1) supplemented with 2% fetal bovine serum, insulin (5 units/ml), CaCl 2 (2 mmol/l), 100 U/ml penicillin and 100 mg/ml streptomycin) with 2 mg/ml Blasticidin. hNCPCs V600E primary cell cultures were established from five fetal scalp tissues, and one adult scalp tissue for comparison. Human NCPCs derived from adult scalp tissue showed similar responses to mutant BRAF as fetal hNCPCs.
Immunoblotting, Immunocytochemistry and immunohistochemistry
Western blotting was done as described previously. 50 Membranes were probed with antibodies against phosphorylated-MAPK, pMEK, MAPK, MEK, CDK2, CDK4, pRB, Ets1/2, PTEN, p16 ink4a (Cell Signaling Technology Inc, Danvers, MA, USA), MITF or b-actin (Sigma Chemicals, St Louis, MO, USA). Blots were probed with horseradish peroxidase-conjugated secondary antibodies (Amersham, Piscataway, NJ, USA) and subjected to enhanced chemiluminescence (Amersham). For immunocytochemistry, hNCPCs RNA isolation and quantitative PCR Total RNA was prepared using the RNeasy kit (Qiagen, Valencia, CA, USA), and cDNAs were prepared using SuperScript First-Strand Synthesis system (Invitrogen, Carlsbad, CA, USA) for RT-PCR according to the manufacture's instruction. RT-PCR analysis was performed using the primers specific for BRAF V600E , MITF and tyrosinase as described previously. 20 b-actin was used as a control.
Luciferase assay 293T cells were seeded in 24-well plates, and transient transfections were performed on the following day using 1.5 ml TurboFectin 8.0 Transfection Reagent (OriGene, Rockville, MD, USA) and MITF promoter-luciferase vectors with or without BRAF V600E vectors in a 50-ml final volume. pRLTK (Renilla) was co-transfected with the plasmids to control transfection efficiency. 24 h after transfection, cells were washed with ice cold 1 Â phosphate-buffered saline (PBS) and cell extracts were prepared and luciferase activity was measured according to the manufacturer's instructions (Promega, Madison, WI, USA).
WST-1 Cell Proliferation assay
Cell proliferation assay was performed according to the manufacture's instructions. Briefly, cultured cells were washed with PBS and suspended to a final concentration of 1 Â 10 5 /ml in assay medium. Aliquots (50 ml) of cell suspensions were dispensed into 96-well plates. The plates were incubated at 37 1C for 24 h in a humidified CO 2 incubator. After the incubation period, WST-1 reagent was added to the cell culture medium (10 ml in 100 ml media) and incubated at 37 1C for 20 min. Plates were shaken vigorously on an orbital shaker for 1 min, and absorbance was measured at 450 nm using a 96-well spectrophotomer plate reader. Experiments were carried out in triplicate.
Cellular senescence assay
Cellular senescence is characterized by the appearance of senescenceassociated b-galactosidase activity in vitro. The cellular senescence assay was performed using a Cellular Senescence Assay Kit (Chemicon, Temecula, CA, USA). Briefly, cells were cultured in 35 mm dishes overnight and then washed once with PBS (pH7.2), incubated with 1 Â fixing solution for 10-15 min and washed twice with PBS. Cells were then stained in 1 Â SA-b-gal detection solution at 37 1C overnight. The detection solution was removed and cells were washed twice with PBS, and bluestained cells were counted under light microscopy.
Soft agar colony formation assay
Five to ten thousand control or BRAF V600E -infected hNCPCs were suspended in 3 ml 1.8% (w/v) BactoAgar solution containing MCDB with 20% fetal bovine serum. The mixtures were overlaid onto a 3.3% (w/v) BactoAgar solution in six-well dishes. On the following day, 2 ml of MCDB supplemented with 10% fetal bovine serum was added. Colonies were counted under a microscope after 15 days. Colony forming efficiency was calculated as: the number of colonies Â 100 divided by the number of cells plated.
Matrigel-GFR invasion assay
Twenty-four-well plates with precoated growth factor reduced Matrigel (Matrigel-GFR) and chambers (BD Biosciences, San Jose, CA, USA) were prepared according to the manufacturer's instructions. The lower well of the chamber was filled with MCDB medium and 10% serum. Cell suspensions (1 Â 10 5 cells) were added to the upper chamber with no growth factors. The plates were incubated for 24 h at 37 1C, non invasive cells were removed from the filter top and the filter was fixed in 1% formaldehyde in PBS. A dilution of the cell samples placed in a 96-well plate served as the loading control. Invading cells and loading controls were stained with 1% crystal violet. Filters were washed in PBS, solubilized in 2% SDS overnight and optical density was determined at 570 nm using a spectrophotometer. Mean±s.d. values were calculated from three repeated observations in each of four separate experiments.
Array CGH CGH was performed using the '1Mb-array' platform developed at the University of Pennsylvania. 51 For hybridization, 1 mg of test DNA and 1 mg of sex-match pooled normal human DNA (obtained from a set of 10 healthy female or male volunteers) were labeled with either Cy3-dCTP or Cy5-dCTP (Amersham Biosciences, Little Chalfont, UK) incorporated by random priming (Bioprime Labeling Kit, Invitrogen). The reaction was then cleaned using the Qiagen MiniElute PCR kit (Qiagen, Valencia, CA, USA). Equal amounts of test and reference DNA (1 mg each) were mixed and precipitated with Cot1-DNA, 3 M NaOAc (pH 7.0) and ethanol. Arrays were hybridized with labeled probes in 50% deionized formamide, 2 Â SSC, 2% Figure 7 . MITF cooperates with BRAF V600E to transform hNCPCs in vivo. hNCPCs V600E and hNCPCs V600E þ MITF (2 million) were injected s.c. into NSG mice; n ¼ 5. These mice were followed for 5 weeks. (a) Mice injected with hNCPCs V600E formed small xenografts, whereas mice injected with hNCPCs V600E þ MITF formed larger tumors. (b) Tumor growth curve. Tumors in mice injected with hNCPCs V600E þ MITF grew rapidly in vivo and these mice had to be killed after 5 weeks. (c) Histology and Ki67 staining of tumor cells in the mouse xenografts. In mice injected with hNCPCs V600E , tumors were confined to areas with Matrigel (arrow points to the Matrigel), whereas mice injected with hNCPCs V600E þ MITF had tumor morphologies similar to human melanoma tumors, with some of the tumor cells infiltrating skeletal muscle (arrow points to the skeletal muscle). The bars in the left panels indicate 150 mm, bars in the middle and right panels indicate 30 mm. Ki67 stains shows most of the hNCPCs V600E þ MITF were proliferative, whereas fewer hNCPCs V600E were proliferative.
SDS, 10% dextran sulfate and 100 mg/ml of yeast tRNA for 72 h at 37 1C in a moist chamber on a slowly rocking table. Slides were washed and arrays were scanned on a GenePix 4000B dual scanner (Axon Instruments, Downingtown, PA, USA).
Data analysis
Fluorescent data from hybridization images were processed and analyzed with Gene Pix Pro 5.0 (Axon Instruments, Union City, CA, USA) to obtain the log 2 ratios (tumor/reference) of each slide. aCGH data were processed through print-tip loess normalization, using the DNMAD application 52 that also allowed us to merge and filter clones between replicates in a slide and in the dye-swap experiment. We filtered out inconsistent replicates (those ones with a log 2 ratio distant to the median log 2 ratio of the replicates 40.3) and those clones that did not have available data in 470% of the cases. For visualization and detection of copy number alteration, 'Analysis of Copy number Errors' algorithm in the CGH-Explorer v. 3.1b software (Softgenetics, State College, PA, USA) was employed. Analysis of copy number errors estimates copy number calls based on genomic regions rather than on individual BACs. The significance is expressed by the estimation of the positive false discovery rate: in our case, the positive false discovery rate chosen was 0.1. 53 
Tumorigenicity analysis
We injected 2 Â 10 6 control hNCPCs or hNCPCs V600E s.c. into the flanks of non-obese diabetic-severe combined immunodeficiency mice (5 mice each group) in 100 ml growth factor reduced Matrigel (BD Biosciences). After tumors were palpable (B2 weeks), caliper measurements were obtained every 3 days. Tumor volume was monitored closely for 8 weeks, at which time the animals were killed. In a second set of experiments, we injected 2 Â 10 6 hNCPCs V600E or hNCPCs V600E þ MITF s.c. into the flanks of NSG mice (5 mice each group) in 100 ml growth factor reduced Matrigel. Owing to rapid tumor growth of the hNCPCs V600E þ MITF , these mice were killed after 5 weeks. All the organs were examined for metastasis grossly and histologically. The tumors were excised and processed for histology and additional analysis.
Statistical analysis
Student's t-test or one-way analysis of variance was used to analyze gene expression, cell viability proliferation data and tumor growth. Statistical significance was determined if two-sided tests yielded Po0.05.
